Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |